DAR No 2: Forxiga® / Edistride®. Dapagliflozin in chronic kidney disease

Content tools

Share it

Good news for some patients with chronic kidney disease

Sodium-glucose cotransporter 2 (SGLT2) inhibitor as second-line treatment combined with ACE-I or ARB in adult patients with chronic kidney disease.

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)

First name, middle initial and last name *

Email *

Current position or occupation *

Place of work *

Suggestions/Comments *